1. bookVolumen 29 (2021): Edición 4 (October 2021)
Detalles de la revista
License
Formato
Revista
eISSN
2284-5623
Primera edición
08 Aug 2013
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Cell Cycle Regulatory CCND1 G870A Gene Polymorphism and Periodontitis-Induced Oral Cancer: A Risk Analysis

Publicado en línea: 22 Oct 2021
Volumen & Edición: Volumen 29 (2021) - Edición 4 (October 2021)
Páginas: 349 - 363
Recibido: 01 Jul 2021
Aceptado: 07 Sep 2021
Detalles de la revista
License
Formato
Revista
eISSN
2284-5623
Primera edición
08 Aug 2013
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015 Mar 1;136(5):E359-86. DOI: 10.1002/ijc.2921010.1002/ijc.2921025220842 Search in Google Scholar

2. Hajishengallis G, Lamont RJ. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. Mol Oral Microbiol. 2012: 27:409-19. DOI: 10.1111/j.2041-1014.2012.00663.x10.1111/j.2041-1014.2012.00663.x365331723134607 Search in Google Scholar

3. Atanasova KR, Yilmaz O. Looking in the Porphyromonas gingivalis cabinet of curiosities: the microbium, the host and cancer association. Mol Oral Microbiol. 2014: 29:55-66. DOI: 10.1111/omi.1204710.1111/omi.12047394914524506890 Search in Google Scholar

4. Whitmore SE, Lamont RJ. Oral bacteria and cancer. PLoS Pathog. 2014: 10:e1003933. DOI: 10.1371/journal.ppat.100393310.1371/journal.ppat.1003933396811824676390 Search in Google Scholar

5. Hooper SJ, Wilson MJ, Crean SJ. Exploring the link between microorganisms and oral cancer: a systematic review of the literature. Head Neck. 2009: 31:1228-39. DOI: 10.1002/hed.2114010.1002/hed.2114019475550 Search in Google Scholar

6. Ahn J, Segers S, Hayes RB. Periodontal Disease, Porphyromonas Gingivalis (P. gingivalis) Serum Antibody Levels and Orodigestive Cancer Mortality. Carcinogen-esis. 2012: 33:1055-8. DOI: 10.1093/carcin/bgs11210.1093/carcin/bgs112333451422367402 Search in Google Scholar

7. Tezal M, Sullivan MA, Hyland A, Marshall JR, Stoler D, Reid ME, Loree TR et al. Chronic periodontitis and the incidence of head and neck squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev. 2009: 18:2406-12. DOI: 10.1158/1055-9965.EPI-09-033410.1158/1055-9965.EPI-09-033419745222 Search in Google Scholar

8. Ahn J, Chen CY, Hayes RB. Oral microbiome and oral and gastrointestinal cancer risk. Cancer Causes Cont. 2012: 23:399-404. DOI: 10.1007/s10552-011-9892-710.1007/s10552-011-9892-7376714022271008 Search in Google Scholar

9. Han YW, Houcken W, Loos BG, Schenkein HA, Tezal M. Periodontal disease, atherosclerosis, adverse pregnancy outcomes, and head-and-neck cancer. Adv Dent Res. 2014: 26:47-55. DOI: 10.1177/002203451452833410.1177/002203451452833424736704 Search in Google Scholar

10. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res. 1995: 55:949-56. Search in Google Scholar

11. Hohberger L, Wuertz BR, Xie H, Griffin T, Ondrey F. TNF-alpha drives matrix metalloproteinase-9 in squamous oral carcinogenesis. Laryngoscope. 2008: 118:1395-9. DOI: 10.1097/MLG.0b013e318174e09b10.1097/MLG.0b013e318174e09b18496150 Search in Google Scholar

12. Jackson-Bernitsas DG, Ichikawa H, Takada Y, Myers JN, Lin XL, Darnay BG et al. Evidence that TNFTNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma. Oncogene. 2007: 26:1385-97. DOI: 10.1038/ sj.onc.120994510.1038/sj.onc.120994516953224 Search in Google Scholar

13. Sherr CJ. Cancer cell cycles. Science. 1996:274(5293):1672-7. DOI: 10.1126/science.274.5293.167210.1126/science.274.5293.16728939849 Search in Google Scholar

14. Witzel II, Koh LF and Perkins ND: Regulation of cyclin D1 gene expression. Biochem Soc Trans 2010: 38:217-22. DOI: 10.1042/BST038021710.1042/BST038021720074063 Search in Google Scholar

15. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J. Alternate splicing produces a novel cyclin D1 transcript. Oncogene. 1995:11(5):1005-11. Search in Google Scholar

16. Soloman DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z, et al. Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem. 2003 :278(16): 30339-47.10.1074/jbc.M30396920012746453 Search in Google Scholar

17. Atac A, Riecke B, Assaf AT, Gröbe A, Friedrich RE, Heiland M et. al. Lack of evidence for predictive and prognostic value of cyclin D1 gene polymorphism CCND1 G870A for oral squamous cell carcinoma. Anticancer Res. 2014:34(1):235-8. Search in Google Scholar

18. Murali A, Nalinakumari KR, Thomas S, Kannan S. Association of single nucleotide polymorphisms in cell cycle regulatory genes with oral cancer susceptibility. Br J Oral Maxillofac Surg. 2014:52(7):652-8. DOI: 10.1016/j.bjoms.2014.05.01010.1016/j.bjoms.2014.05.01024947332 Search in Google Scholar

19. Liu W, Zhu E, Wang R, Wang L, Gao L, Yang X, Liu T. Cyclin D1 gene polymorphism, A870G, is associated with an increased risk of salivary gland tumors in the Chinese population. Cancer Epidemiol. 2011:35(4):e12-7. DOI: 10.1016/j.canep.2010.11.00110.1016/j.canep.2010.11.00121185249 Search in Google Scholar

20. Tsai MH, Tsai CW, Tsou YA, Hua CH, Hsu CF, Bau DT. Significant association of cyclin D1 single nucleotide polymorphisms with oral cancer in taiwan. Anticancer Res. 2011:31(1):227-31. Search in Google Scholar

21. Gomes CC, Drummond SN, Guimarães AL, Andrade CI, Mesquita RA, Gomez RS. P21/WAF1 and cyclin D1 variants and oral squamous cell carcinoma. J Oral Pathol Med. 2008:37(3):151-6. DOI: 10.1111/j.1600-0714.2007.00604.x10.1111/j.1600-0714.2007.00604.x18251939 Search in Google Scholar

22. Sathyan KM, Nalinakumari KR, Abraham T, Kannan S. Influence of single nucleotide polymorphisms in H-Ras and cyclin D1 genes on oral cancer susceptibility. Oral Oncol. 2006:42(6):607-13. DOI: 10.1016/j.oraloncology.2005.10.01910.1016/j.oraloncology.2005.10.01916488657 Search in Google Scholar

23. Holley SL, Matthias C, Jahnke V, Fryer AA, Strange RC, Hoban PR. Association of cyclin D1 polymorphism with increased susceptibility to oral squamous cell carcinoma. Oral Oncol. 2005:41(2):156-60. DOI: 10.1016/j.oraloncology.2004.08.00510.1016/j.oraloncology.2004.08.00515695117 Search in Google Scholar

24. Nishimoto IN, Pinheiro NA, Rogatto SR, Carvalho AL, Simpson AJ, Caballero OL et al. Cyclin D1 gene polymorphism as a risk factor for squamous cell carcinoma of the upper aerodigestive system in non-alcoholics. Oral Oncol. 2004:40(6):604-10. DOI: 10.1016/j. oraloncology.2003.12.009 Search in Google Scholar

25. Wong YK, Lin SC, Chang CS, Tseng YH, Liu CJ, Lin HC et al. Cyclin D1 genotype in areca-associated oral squamous cell carcinoma. J Oral Pathol Med. 2003:32(5):265-70. DOI: 10.1034/j.1600-0714.2003.00131.x10.1034/j.1600-0714.2003.00131.x12694349 Search in Google Scholar

26. Zheng Y, Shen H, Sturgis EM, Wang LE, Eicher SA, Strom SS et al. Cyclin D1 polymorphism and risk for squamous cell carcinoma of the head and neck: a case-control study. Carcinogenesis. 2001:22(8):1195-9. DOI: 10.1093/carcin/22.8.119510.1093/carcin/22.8.1195 Search in Google Scholar

27. Matthias C, Branigan K, Jahnke V, Leder K, Haas J, Heighway J et al. Polymorphism within the cyclin D1 gene is associated with prognosis in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res. 1998:4(10):2411-8. Search in Google Scholar

28. Munafo MR, Flint J. Meta-analysis of genetic association studies. Trends Genet. 2004:20(9):439-44. DOI: 10.1016/j.tig.2004.06.01410.1016/j.tig.2004.06.014 Search in Google Scholar

29. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010: 25: 603-5. DOI: 10.1007/s10654-010-9491-z10.1007/s10654-010-9491-z Search in Google Scholar

30. Wu R, Li B. A multiplicative-epistatic model for analyzing interspecific differences in outcrossing species. Biometrics. 1999:2:355-65. DOI: 10.1111/j.0006-341X.1999.00355.x10.1111/j.0006-341X.1999.00355.x Search in Google Scholar

31. Der Simonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986:7:177-88. DOI: 10.1016/0197-2456(86)90046-210.1016/0197-2456(86)90046-2 Search in Google Scholar

32. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959:4:719-48. Search in Google Scholar

33. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997: 315:629-34. DOI: 10.1136/ bmj.315.7109.62910.1136/bmj.315.7109.62921274539310563 Search in Google Scholar

34. Wetterslev, J., Thorlund, K., Brok, J., Gluud, C. Trial sequential analysis may establish when firm evidence is reached in cumulative metaanalysis. J. Clin. Epidemiol. 2008:61: 64-75. DOI: 10.1016/j.jclinepi.2007.03.01310.1016/j.jclinepi.2007.03.01318083463 Search in Google Scholar

35. d Brok, J., Thorlund, K., Wetterslev, J., and Gluud, C. Apparently conclusive meta-analyses may be inconclusive-Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses. Int. J. Epidemiol 2009: 38: 287-98. DOI: 10.1093/ije/dyn18810.1093/ije/dyn18818824466 Search in Google Scholar

36. Turner, R. M., Bird, S. M., and Higgins, J. P. The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews. PLoS ONE 2013: 8: e59202. DOI: 10.1371/journal.pone.005920210.1371/journal.pone.0059202360974523544056 Search in Google Scholar

37. Wilson S, Jones L, Couseens C, Kathi H. The links between environmental factors, genetics, and the development of Cancer. Cancer and the Environment: Gene-Enviroment Interaction. National Academies Press (US), 2002. Search in Google Scholar

38. Morgan, David O. Principles of CDK regulation. Nature 374, no. 6518 (1995): 131-4. DOI: 10.1038/374131a010.1038/374131a07877684 Search in Google Scholar

39. Dowdy, Steven F., Philip W. Hinds, Kenway Louie, Steven I. Reed et al. Weinberg. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 1993:73(3): 499-511. DOI: 10.1016/0092-8674(93)90137-F10.1016/0092-8674(93)90137-F Search in Google Scholar

40. Donnellan, R., and R. Chetty. Cyclin D1 and human neoplasia. Molecular Pathology 1998):51:1. DOI: 10.1136/mp.51.1.110.1136/mp.51.1.1 Search in Google Scholar

41. Schoelch ML, Regezi. Cell cycle proteins the development of oral squamous cell carcinoma. Oral Oncol 1999: 35:333-42. DOI: 10.1016/S1368-8375(98)00098-010.1016/S1368-8375(98)00098-0 Search in Google Scholar

42. Todd R, Hind PW, Munger K, Rustgi AK, Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med 2002:13:51-61. DOI: 10.1177/15441113020130010610.1177/154411130201300106 Search in Google Scholar

43. Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H, et al. Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene. 1998:16(13):1701-12. DOI: 10.1038/ sj.onc.120169110.1038/sj.onc.1201691 Search in Google Scholar

44. Hall M, Peters G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res.1996:68:67-108. DOI: 10.1016/S0065-230X(08)60352-810.1016/S0065-230X(08)60352-8 Search in Google Scholar

45. Wang L, Wang Z, Gao X, Li X, Sun X, Liu C. Association between Cyclin D1 polymorphism and oral cancer susceptibility: a meta-analysis. Tumour Biol. 2014:35(2):1149-55. DOI: 10.1007/s13277-013-1154-810.1007/s13277-013-1154-824186074 Search in Google Scholar

46. Wang W, Zhao Y, Yang J, Lin B, Gu H, Cao X et al. Cyclin D1 polymorphism and oral cancer: a meta-analysis. Mol Biol Rep. 2013:40(1):87-95. DOI: 10.1007/ s11033-012-2025-x10.1007/s11033-012-2025-x23111452 Search in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo